Our head of SEND Services and Chief Toxicologist at PointCross Life Sciences collaborated on a whitepaper on how to assess your SEND readiness. To access the full document, please click here. We have also summarized the document below.
[…]
PointCross Blog
Our Recent Blog
FOSTER CITY, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) — PointCross Life Sciences came out of stealth mode with its Xbiom™ Insights solution for Clinical Biomarker research. With two clients deployed, PointCross is now acquiring new pharma and biotechnology companies who […]
PointCross Life Sciences Announces SaaS Environment for FDA Nonclinical Study Data Reviewer Analytics and Submissions
FOSTER CITY, CA, June 6, 2013 PRNewswire
PointCross Life Sciences today announced the immediate availability of a multi-tenant software as a service (SaaS) environment […]
In case you missed our announcement made in December 2016; PointCross is happy to announce availability of it’s Validator to the public free of charge.
To date, there is no validator available on the market which focuses solely on […]
CIMS™, the PointCross Life Science built Repository for Clinical SDTM Data is now available to Pharma sponsors with compliant standardized NDA submissions to FDA guidance.
Silver Spring, MD, March 14, 2016
PointCross Life Sciences today announced its […]
RDIS™ and iOmics™ integration arcs across nonclinical, clinical and genomic biomarkers for targeted therapeutic drug development and stratified patient selection
Foster City, CA, April 20, 2015 /PRNewswire/ — PointCross Life Sciences today announced a strategic partnership with InterpretOmics […]
XYBION AND POINTCROSS ESTABLISH A STRATEGIC PARTNERSHIP TO DELIVER SEND SERVICES TO ASSURE FDA REVIEW READY SUBMISSIONS
March 11, 2016: PointCross Life Sciences and Xybion announced today a strategic partnership to provide the Biopharma industry with a complete […]
PointCross Life Sciences Announces DSIMS™: Drug Safety Information Management Suite
FOSTER CITY, CA, March 12, 2012 PRNewswire
The FDA has announced its intention to require Pharma companies to include nonclinical study data in standardized electronic formats as […]
PointCross Life Sciences to Provide the FDA With Nonclinical Study Data Software and Services
FOSTER CITY, Calif., Oct. 3, 2011 PRNewswire
PointCross Life Sciences, Inc. has announced that it has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) […]
PointCross Life Sciences Named to Gartner’s Cool Vendor 2013 List for Life Sciences
FOSTER CITY, CA, May 15, 2013
PointCross Life Sciences announced today that it has been included in the list of “Cool Vendors in Life […]
Company
-
Our Recent Blog
- Benchmark your SEND Readiness January 29, 2018
- PointCross Inks two deals for its Xbiom™ Insights – Clinical Biomarker Platform for Precision Medicine Development February 15, 2017
- PointCross Life Sciences Announces SaaS Environment for FDA Nonclinical Study Data Reviewer Analytics and Submissions January 19, 2017
- Introducing the PointCross Desktop Validator January 19, 2017
- PointCross Life Sciences’ Clinical Data Repository for SDTM data fills an urgent gap January 19, 2017
- PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development January 19, 2017
- PointCross Life Sciences and Xybion forge strategic partnership to deliver SEND services to assure FDA review ready submissions January 19, 2017
- PointCross Life Sciences Announces DSIMS™: Drug Safety Information Management Suite January 19, 2017
Ready to learn more?
Stay up-to-date by signing up for our personalized newsletters or scheduling a call with a local team member to better understand your specific needs.
Contact Us Request a Demo
About Us
PointCross Life Sciences Inc. delivers proven technology to support drug development through a suite of Nonclinical
and Clinical offeringsSolutions
Quick Links
Contact
1291 E. Hillsdale Blvd, Suite 304
Foster City, California 94404 USADirect: +1 (650) 350 – 1900
Toll Free: +1 (844) 382 – 7257
get_started@pointcross.comFollow us